Chinese traditional medicine injection won the highest award of intellectual property in China

China patent award ceremony, known as "Oscar" of China intellectual property circles, was held in Beijing on November 11, 2013 Kangyuan pharmaceutical's invention patent "a drug for clearing heat and detoxifying and its preparation method" recommended by Jiangsu Intellectual Property Office won the gold medal of the 15th China Patent Award The award ceremony was co sponsored by the State Intellectual Property Office and the world intellectual property organization Francis Gore, director general of the world intellectual property organization, attended the ceremony and delivered a speech Tian Lipu, director of the State Intellectual Property Office, attended the conference and delivered a speech The purpose of the China patent award is to recognize the patentees, inventors and designers who have made outstanding contributions to actively using the intellectual property system, promoting technological innovation and promoting economic and social development The selection of this China patent award has gathered strength and innovation, and has received strong support from all departments and wide attention from all walks of life The relevant departments of the State Council, relevant national industry associations, academicians of the two academies and all provinces, districts and cities all over the country attach great importance to the selection of this China Patent Award Nearly 800 excellent projects have been recommended, and the number of participants has reached a new record According to the evaluation of the State Intellectual Property Office and the world intellectual property organization, 20 projects of China Patent Gold Award and 336 projects of China Patent Excellence Award were awarded in the 15th session It is closely related to the continuous independent innovation of Kangyuan Pharmaceutical Co., Ltd After years of intensive research, the results of Reduning Injection came into the market in 2005, and it is the first new Chinese medicine injection approved after the implementation of the 2005 version of the measures for the administration of drug registration After the launch of Reduning injection, Kangyuan pharmaceutical continued to study the material basis, mechanism and quality control of the product Through in-depth study, the chemical structure of Reduning injection is more than 75%, and the measurable components are more than 85% Combined with the network pharmacological method and in vitro and in vivo experimental verification, the antiviral and anti-inflammatory active components and mechanism are basically defined Kangyuan pharmaceutical established a quality control system for the whole production process of Reduning injection, including 16 fingerprints, 247 quality control items and 460 SOP Research shows that Reduning injection can fight against EV71, H1N1, H5N1, H3N2, h7n9 and other viruses, with a total clinical effective rate of more than 99%, which is obviously superior to the similar drugs in the market; compared with chemical drugs, Reduning injection has the characteristics of rapid antipyretic without rebound, and has no drug resistance It has been listed in the national emergency reserve medicine for influenza prevention and control, the national medical insurance catalogue, the diagnosis and treatment guide for hand, foot and mouth disease of the Ministry of health, the diagnosis and treatment plan for influenza A (H1N1), and the diagnosis and treatment plan for human infection with h7n9 avian influenza, making outstanding contributions to the prevention and treatment of influenza A, hand, foot and mouth disease, avian influenza and other epidemic diseases The core patent technology of Reduning injection of Kangyuan pharmaceutical won the gold medal of China Patent Award, which is of milestone significance for the development of Chinese traditional medicine injection and will play a positive role in promoting the development of Chinese traditional medicine injection Kangyuan pharmaceutical will also take this opportunity to continue to increase efforts and investment in new drug research and development and intellectual property protection, create high-quality national drugs, serve the people's health and contribute to the realization of the Chinese dream.